PULMICORT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug PULMICORT contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PULMICORT TURBOHALER 100 Breath-actuated metered dose powder inhaler	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AD05	Budesonide	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD05
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2065Q, 2066R, 2070Y, 2071B, 2072C
BR	Câmara de Regulação do Mercado de Medicamentos	502303101170311, 502303102177311, 502303103173318, 502303104171319
CA	Health Products and Food Branch	00851752, 00851760, 00852074, 01978918, 01978926, 02229099
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00278480, 04814998, 07727484
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5696-MEE-1120
EE	Ravimiamet	1038316, 1057542, 1057553, 1114827
ES	Centro de información online de medicamentos de la AEMPS	59254, 59255, 59297, 59298, 62046
FI	Lääkealan turvallisuus- ja kehittämiskeskus	121277, 403998, 482612, 482646, 501502, 501528
FR	Base de données publique des médicaments	65036357, 65546488, 65773258, 66664532, 68441909
GB	Medicines & Healthcare Products Regulatory Agency	139523, 139526, 139538, 143830, 143866, 143880, 143903, 162301, 162303, 162307, 162310, 162315, 181755, 31126, 31132, 32291, 36357, 36368
HK	Department of Health Drug Office	33964, 33965, 34493, 36958, 36959
HR	Agencija za lijekove i medicinske proizvode	HR-H-217872273
IE	Health Products Regulatory Authority	40746, 40754, 40800, 40819, 40991, 43578
JP	医薬品医療機器総合機構	2290701G1039, 2290701G2035, 2290701G3031, 2290701G4020, 2290701G5026
MT	Medicines Authority	MA046/01401, MA046/01402, MA046/01405, MA046/01407
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	001M99, 590M95
NL	Z-Index G-Standaard	12506753, 13543954, 13578111, 13601601, 13642790, 13667246
NL	Z-Index G-Standaard, PRK	34452, 35238, 35416, 66427, 66885
NZ	Medicines and Medical Devices Safety Authority	3950, 3951, 3952
PL	Rejestru Produktów Leczniczych	100056658, 100056664, 100089729, 100089735, 100089741, 100351245, 100351251, 100368270, 100461589
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W00680001
SG	Health Sciences Authority	05042P, 05043P, 07461P, 07467P
TN	Direction de la Pharmacie et du Médicament	5103053
TR	İlaç ve Tıbbi Cihaz Kurumu	8699786520011, 8699786520028, 8699786550025, 8699786550032, 8699786550049
US	FDA, National Drug Code	0186-0916, 0186-0917, 0186-1988, 0186-1989, 0186-1990
ZA	Health Products Regulatory Authority	Y/21.5.1/171, Y/21.5.1/172, Z/21.5.1/266